Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, and hospital quality reporting issues.
Advancing key federal appropriations priorities for the National Healthcare Safety Network, Project Firstline, the Prevention and Public Health Fund via the FY 2025 budget and appropriations process.
Duration: January 1, 2021
to
present
General Issues: Health Issues , Budget/Appropriations
Spending: about $260,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Centers For Disease Control & Prevention (CDC), Occupational Safety & Health Administration (OSHA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Billy Wynne
Health Policy Counsel, Senate Finance Committee
Katie Pahner
Health Insurance Specialist, Centers for Medicare and Medicaid Services (CMS)
Alyson Lewis
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Impact Health Policy Partners lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on April 18.
Original Filing: 301552760.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, and hospital quality reporting issues.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities for the National Healthcare Safety Network, Project Firstline, the Prevention and Public Health Fund via the FY 2025 budget and appropriations process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
4th Quarter, 2023
In Q4, Impact Health Policy Partners lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on Jan. 18.
Original Filing: 301527677.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, and hospital quality reporting issues.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities for the National Healthcare Safety Network, Project Firstline, the Prevention and Public Health Fund via the FY 2024 budget and appropriations process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
3rd Quarter, 2023
In Q3, Impact Health Policy Partners lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on Oct. 17, 2023.
Original Filing: 301502180.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, and hospital quality reporting issues.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities for the National Healthcare Safety Network, Project Firstline, the Prevention and Public Health Fund via the FY 2024 budget and appropriations process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
2nd Quarter, 2023
In Q2, Impact Health Policy Partners (formerly known as Wynne Health Group) lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on July 18, 2023.
Original Filing: 301479919.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, and hospital quality reporting issues. Pandemic and All Hazards Preparedness Reauthorization Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities for the National Healthcare Safety Network, Project Firstline, the Prevention and Public Health Fund via the FY 2024 budget and appropriations process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
1st Quarter, 2023
In Q1, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on April 19, 2023.
Original Filing: 301458494.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, and hospital quality reporting issues. Pandemic and All Hazards Preparedness Reauthorization Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities for the National Healthcare Safety Network, Project Firstline, the Prevention and Public Health Fund via the FY 2024 budget and appropriations process.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
4th Quarter, 2022
In Q4, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on Jan. 13, 2023.
Original Filing: 301427397.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues. H.R.6000, Cures 2.0 Act. S. 3799, PREVENT Pandemics Act. H.R.2617, Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities for the National Healthcare Safety Network, Project Firstline, the Prevention and Public Health Fund via the FY 2023 budget and appropriations process. H.R.2617, Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
3rd Quarter, 2022
In Q3, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on Oct. 12, 2022.
Original Filing: 301403023.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues.
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R. 5376, FY 2022 Budget Reconciliation; H.R.2471, Consolidated Appropriations Act, 2022 (P.L. 117-103); H.R.6000, Cures 2.0 Act; and S. 3799, PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities in FY 2022 appropriations legislation, Consolidated Appropriations Act, 2022 (P.L. 117-103), for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund. Also, issues pertaining to FY 2023 budget and appropriations.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
2nd Quarter, 2022
In Q2, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on July 15, 2022.
Original Filing: 301380669.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues.
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R. 5376, FY 2022 Budget Reconciliation; H.R.2471, Consolidated Appropriations Act, 2022 (P.L. 117-103); H.R.6000, Cures 2.0 Act; and S. 3799, PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities in FY 2022 appropriations legislation, Consolidated Appropriations Act, 2022 (P.L. 117-103), for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund. Also, issues pertaining to FY 2023 budget and appropriations.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
1st Quarter, 2022
In Q1, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on April 18, 2022.
Original Filing: 301359499.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues.
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R. 5376, FY 2022 Budget Reconciliation; H.R.2471, Consolidated Appropriations Act, 2022 (P.L. 117-103); H.R.6000, Cures 2.0 Act; and S. 3799, PREVENT Pandemics Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
Lobbying Issues
Advancing key federal appropriations priorities in FY 2022 appropriations legislation, Consolidated Appropriations Act, 2022 (P.L. 117-103), for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund. Also, issues pertaining to FY 2023 budget and appropriations.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Disease Control & Prevention (CDC) Occupational Safety & Health Administration (OSHA)
4th Quarter, 2021
In Q4, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on Jan. 14, 2022.
Original Filing: 301322740.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues.
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Advancing key federal appropriations priorities in FY 2022 appropriations legislation for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on Oct. 16, 2021.
Original Filing: 301300376.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues.
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Advancing key federal appropriations priorities in FY 2022 appropriations legislation for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on July 16, 2021.
Original Filing: 301277631.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues.
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Advancing key federal appropriations priorities in FY 2022 appropriations legislation for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, Wynne Health Group lobbied for Society for Healthcare Epidemiology of America (SHEA) , earning $20,000. The report was filed on April 20, 2021.
Original Filing: 301260020.xml
Lobbying Issues
Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues.
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Advancing key federal appropriations priorities in FY 2022 appropriations legislation for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
Wynne Health Group filed a lobbying registration on Feb. 2, 2021 to represent Society for Healthcare Epidemiology of America (SHEA), effective Jan. 1, 2021.
Original Filing: 301247449.xml
Issue(s) they said they’d lobby about: Issues related to federal policies and programs that aim to improve patient outcomes and quality of healthcare by limiting the prevalence of healthcare-associated infections and antibiotic resistance. This includes health equity; emergency preparedness and outbreak response, especially as it pertains to COVID-19; and hospital quality reporting issues. Also includes advancing key federal appropriations priorities in FY 2022 appropriations legislation for the National Healthcare Safety Network; Project Firstline; and the Prevention and Public Health Fund. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate